IP Library Granted Patent US 8,247,373
Granted Patent B2
US 8,247,373 · App. 13/227,871 · Granted Aug 21, 2012

Lactoferrin compositions and methods of wound treatment

Assignee: Agennix Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,247,373
App. No.
13/227,871
Granted
Aug 21, 2012
Kind
B2
Abstract

The present invention relates to lactoferrin compositions and methods of using the compositions to treat wounds. The compositions can be administered alone or in combination with other standard wound healing therapies.

Claims (11)

1. A method of treating a skin wound comprising the step of administering 0.0001 microgram to 100 g per day of lactoferrin to a subject having a skin wound selected from the group consisting of a chronic ulcer, a laceration, a penetrating wound, a surgical wound or an open full thickness skin puncture wound to result in improved wound closure.

2. The method of claim 1 , wherein the lactoferrin is administered topically, orally or parenterally.

3. The method of claim 2 , wherein the lactoferrin is administered topically.

4. The method of claim 3 , wherein the lactoferrin is administered in a gel.

5. The method of claim 2 , wherein the lactoferrin is administered orally.

6. The method of claim 5 , further comprising administering an antacid in conjunction with the lactoferrin.

7. The method of claim 2 , wherein the lactoferrin composition is administered parenterally.

8. The method of claim 1 , further comprising administering an additional wound healing therapy in combination with the lactoferrin.

9. The method of claim 1 , wherein the administering comprising administering the lactoferrin for at least one week to twelve weeks.

10. The method of claim 1 , wherein the lactoferrin is comprised in a topical gel, a solution, a capsule or a tablet having a lactoferrin concentration of about 0.0001% to about 30%.

11. The method of claim 1 , wherein the chronic ulcer is a diabetic ulcer, a venous stasis ulcer, or a pressure ulcer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2012
From: ENGELMAYER, JOSE; VARADHACHARY, ATUL
To: AGENNIX INCORPORATED
Reel/Frame 028267/0117 →
Continuity (4)
Continuation 12403250 · Mar 12, 2009
Continuation 10663258 · Sep 16, 2003
Provisional Application 60410981 · Sep 16, 2002
Related Publication 20120010150A1 · Jan 12, 2012